Limited treatment options are currently available for psoriasis, including topical corticosteroids, oral anti-inflammatory medications, biologic therapies, and phototherapy.1 Phototherapy is a cost-effective alternative that has demonstrated excellent efficacy and safety, leading to better patient-reported outcomes.1 Phototherapy also improves cardiovascular biomarkers and does not carry a risk of infection.1 While a survey of more than 2,500 psoriasis patients and 1,000 dermatologists across the United States revealed that phototherapy remains a preferred treatment option, particularly for home phototherapy among patients, barriers such as inconvenience, accessibility, and insufficient insurance coverage hinder its use.1